Clinical Trial Update: Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating human papillomavirus vaccination to protect young special-risk females from cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Cervical Cancer | Phase 3 | Status: COMPLETED